Answers are grounded in this paper and cite their sources.
Background Although thymol and carvacrol (CAT) have been shown to alleviate diarrhea in 3-month-old Tibetan cashmere goat kids, it remains unclear whether CAT exert these effects by remodeling the intestinal microbiota and modulating metabolite-associated mucin responses. Results Here, we established an acute E. coli O157:H7 challenge-associated intestinal disturbance model in 3-month-old goat kids by intraperitoneal injection and used integrated multi-omics analyses to investigate the effects of CAT. CAT treatment significantly remodeled the intestinal microbiota, reduced the abundance of E. coli , and enriched the potential commensal bacterium Romboutsia maritimum . Metabolomic analysis showed that CAT significantly increased benzyl cinnamate (BzC), which was positively correlated with R. maritimum and IL-10. Genome-based functional annotation indicated that R. maritimum harbors genes annotated to phenylpropanoid-related pathways, suggesting predicted metabolic potential that may be associated with BzC-related metabolism. In parallel, proteomic analysis revealed that CAT upregulated proteins involved in mucin-type O-glycosylation in intestinal epithelial tissues, with GALNT7 identified as a key responsive protein. Functional assays further demonstrated that BzC promoted MUC2 expression in a GALNT7-dependent manner, thereby supporting mucin-associated barrier responses and attenuating diarrhea-related intestinal alterations. Conclusions These findings identify a potential microbiota–metabolite regulatory pathway by which CAT protects against intestinal inflammation in young goat kids and provide new insights into microbiota-based strategies for controlling diarrhea in young ruminants.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: